QC
IDXX icon

Quent Capital’s Idexx Laboratories IDXX Stock Holding History

Quent Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Buy
252
+5
+2% +$3.21K 0.01% 461
2025
Q4 		$167K Buy
247
+6
+2% +$4.09K 0.01% 428
2025
Q3 		$154K Buy
+241
New +$146K 0.01% 328
2025
Q2 		– Sell
-236
Closed -$99.1K – 743
2025
Q1 		$99.1K Buy
236
+2
+0.9% +$868 0.01% 399
2024
Q4 		$96.7K Sell
234
-21
-8% -$9.21K 0.01% 417
2024
Q3 		$129K Buy
255
+8
+3% +$3.89K 0.01% 428
2024
Q2 		$120K Sell
247
-9
-4% -$4.52K 0.01% 420
2024
Q1 		$138K Buy
256
+11
+4% +$6.01K 0.02% 410
2023
Q4 		$136K Buy
245
+94
+62% +$44.1K 0.02% 376
2023
Q3 		$66K Sell
151
-6
-4% -$2.99K 0.01% 519
2023
Q2 		$78.8K Hold
157
– – 0.01% 483
2023
Q1 		$78.5K Hold
157
– – 0.01% 472
2022
Q4 		$64K Sell
157
-248
-61% -$96.3K 0.01% 517
2022
Q3 		$132K Sell
405
-50
-11% -$18.4K 0.03% 319
2022
Q2 		$160K Sell
455
-70
-13% -$28.5K 0.03% 265
2022
Q1 		$287K Sell
525
-1,041
-66% -$548K 0.05% 217
2021
Q4 		$1.03M Buy
+1,566
New +$983K 0.22% 77

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quent Capital's IDXX Position: Q1 2026 in Review

Quent Capital increased its Idexx Laboratories (IDXX) stake by 2% in Q1 2026, buying an estimated $3.21K and bringing the position to 252 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #461.

Quent Capital first reported a position in IDXX in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.03M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Quent Capital held 252 shares of Idexx Laboratories worth $142K as of Q1 2026.
  • Quent Capital bought 5 Idexx Laboratories shares in Q1 2026, an estimated $3.21K.
  • Idexx Laboratories made up 0.01% of Quent Capital's portfolio in Q1 2026, its #461 holding.
  • Quent Capital first reported a position in Idexx Laboratories in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Idexx Laboratories position peaked at $1.03M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.